Germany The biggest pharma industry and healthcare stories from Germany, including the country’s legalisation of cannabis; the MASH potential of Boehringer Ingelheim’s obesity candidate; Bayer’s further share price drop and expansion into the US; the antibody-drug conjugate (ADC) specialist Tubulis’ series B2 financing, and Novartis’ deal with biotech MorphoSys. Germany’s…
Mexico Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational marijuana. With a population of nearly 130 million people, Mexico would join Canada and Uruguay as the only countries to legalise marijuana at the national level in the continent and it would become the…
Puerto Rico HRP Labs, the largest operator of pathology and specialized laboratories in Puerto Rico, is leading the way in the post-Hurricane Maria industry. Guillermo Villarmarzo, in-house legal counselor, and Gabriela Villarmarzo, chief compliance officer, discuss the company’s strategy to continue serving Puerto Rico’s healthcare system in benefit of the patients and…
China Fangda Partners’ Josh Shin gives an overview of recent regulatory upgrades affecting the Chinese pharmaceutical industry. On August 26, 2019, China enacted the Amended Drug Administration Law as part of its efforts to strengthen and streamline its regulation of the pharmaceutical industry. The amended law seeks to address prominent…
Opinion Within the pharmaceutical space, Eurasia Group’s Aditya Bhattacharji expects politics to drive significant changes in regulatory and legal affairs. He explains how the evolving dynamics can be characterized by two themes. Regulatory Right-Sizing The status quo is highly unlikely to hold in the regulatory space. The growing and largely…
South Korea Southeast Asia’s notoriously strict anti-cannabis laws could be set to relax dramatically as South Korea becomes the first country in the region to legalise cannabis for medicinal use. This surprising move towards legalisation is intended to expand treatment options for patients suffering from rare diseases such as epilepsy. …
Cannabis Following the death penalty handed to Muhammad Lukman, a 29-year old man who was convicted of possessing, processing and distributing medicinal cannabis oil, public outcry has caused Malaysian officials to reconsider the punishment. Muhammad Lukman was arrested in 2015 for possessing 3.1 litres of cannabis oil, 279 g of compressed cannabis and 1.4 kg of…
Bulgaria Gergana Semova and Petko Konakchiev, founders of PharmDedict, share an overview of the Bulgarian regulatory dynamism, the reasons why healthcare companies should continue investing in the country, and explain why PharmDedict is not only a service provider, but also a solutions provider. After having worked for several years in the…
A Regulatory Overview of the Mexican Healthcare market by ALEJANDRO LUNA FANDIÑO, Partner Olivares & Cia. Olivares & Cia T +52 55 5322 3080 F +52 55 5322 3001 E mailto:alf@olivares.com.mx W www.olivares.com.mx I. Pricing & Reimbursement. Price control in the private sector is based on a scheme of self-…
See our Cookie Privacy Policy Here